On Dihydroorotate Dehydrogenases and Their Inhibitors and Uses

Munier-Lehmann, Hélène, Vidalain, Pierre-Olivier, Tangy, Frédéric, Janin, Yves L.·2013·Journal of Medicinal Chemistry

Cited by (236)

Items 201–236 of 236

  1. Molecular Target Discovery and Systemic Mechanism Analysis of Teriflunomide for Dry Eye Disease
    Yuehua Chen, Weiran Lin, Wei Feng, Wenyuan Li, Lianhao Song · 2026 · Current Issues in Molecular Biology
  2. DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity
    Alexandra Herrmann, Friedrich Hahn, Christina Wangen, Sabrina Wagner, Arne Cordsmeier, Pascal Irrgang, Tatjana Weil, Victoria Hunszinger, Rüdiger Groß, Natalie Heinen et al. · 2026 · Journal of Medicinal Chemistry
  3. Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4‐mediated cell death in TP53 ‐deficient ALL
    Kari J. T. Grünewald, Marjolein M G Kes, Gawin R. Stoll, Willem P. J. Cox, Dorette van Ingen Schenau, Enzo M. Scutigliani, Emmely M. Wagener, Ziqin Tang, Senna Visser, Jolanda Kooiman et al. · 2026 · HemaSphere
  4. Multiple Sklerose und rheumatoide Arthritis: Überschneidungen und Interferenzen bei den Therapiekonzepten
    Franz Felix Konen, Torsten Witte, Marc Pawlitzki, Sven G. Meuth, Thomas Skripuletz · 2026 · Deutsches Ärzteblatt
  5. Discovery of Potential Fungal Dihydroorotate Dehydrogenase Inhibitors Via Structure-based Virtual Screening for Plant Disease Control
    Guo‐Tai Lin, Jia-Qi Wu, Jia-Yi Zhu, Ming-Hui Yin, Li Luo, Dan Qian Xu, Xili Liu, Gong Xu · 2026 · Journal of Agricultural and Food Chemistry
  6. Is the pyrimidine the proton-handling element of the genetic alphabet? A quantum-chemical test of a proton-centred account of infectious disease
    Shrish Chandra Srivastava · 2026 · Research Square
  7. Brequinar Exerts Antiviral Effects Against Aquareovirus via Host Pyrimidine Metabolism Modulation
    Linyi Liu, Weijun Wu, Sen Han, Liqun Lu · 2026 · Journal of Fish Diseases
  8. BindingDB Entry 50013642: Low cytotoxic quinoline-4-carboxylic acids derived from vanillin precursors as potential human dihydroorotate dehydrogenase inhibitors.
    BindingDB · 2022 · UC San Diego
  9. BindingDB Entry 50016438: Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
    BindingDB · 2023 · UC San Diego
  10. BindingDB Entry 50046110: Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH).
    BindingDB · 2016 · UC San Diego
  11. BindingDB Entry 50015235: Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease.
    BindingDB · 2023 · UC San Diego
  12. BindingDB Entry 50008881: Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
    BindingDB · 2021 · UC San Diego
  13. BindingDB Entry 50011617: Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors.
    BindingDB · 2022 · UC San Diego
  14. BindingDB Entry 50020851: Discovery and Optimization of Novel
    BindingDB · 2024 · UC San Diego
  15. BindingDB Entry 50012083: A carboxylic acid isostere screen of the DHODH inhibitor Brequinar.
    BindingDB · 2022 · UC San Diego
  16. BindingDB Entry 50049169: Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.
    BindingDB · 2019 · UC San Diego
  17. BindingDB Entry 50009286: Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.
    BindingDB · 2021 · UC San Diego
  18. BindingDB Entry 50015476: Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.
    BindingDB · 2023 · UC San Diego
  19. BindingDB Entry 50044463: Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors.
    BindingDB · 2015 · UC San Diego
  20. BindingDB Entry 50012657: N-phenyl ureidobenzenesulfonates, a novel class of promising human dihydroorotate dehydrogenase inhibitors.
    BindingDB · 2022 · UC San Diego
  21. BindingDB Entry 50014419: Targeting Chikungunya Virus Replication by Benzoannulene Inhibitors.
    BindingDB · 2022 · UC San Diego
  22. BindingDB Entry 50045625: Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase.
    BindingDB · 2016 · UC San Diego
  23. BindingDB Entry 50003041: Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
    BindingDB · 2020 · UC San Diego
  24. BindingDB Entry 50010583: Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability.
    BindingDB · 2021 · UC San Diego
  25. BindingDB Entry 50048029: Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia.
    BindingDB · 2018 · UC San Diego
  26. BindingDB Entry 50043446: TBA
    BindingDB · 2014 · UC San Diego
  27. BindingDB Entry 50045613: Original 2-(3-alkoxy-1H-pyrazol-1-yl)pyrimidine derivatives as inhibitors of human dihydroorotate dehydrogenase (DHODH).
    BindingDB · 2016 · UC San Diego
  28. BindingDB Entry 50003270: Lead-like Drugs: A Perspective.
    BindingDB · 2020 · UC San Diego
  29. BindingDB Entry 50011749: Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition.
    BindingDB · 2022 · UC San Diego
  30. BindingDB Entry 50046135: Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH.
    BindingDB · 2016 · UC San Diego
  31. BindingDB Entry 50019934: Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold.
    BindingDB · 2024 · UC San Diego
  32. BindingDB Entry 50048288: Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase.
    BindingDB · 2018 · UC San Diego
  33. BindingDB Entry 50001475: Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
    BindingDB · 2020 · UC San Diego
  34. BindingDB Entry 50002707: Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate Dehydrogenase.
    BindingDB · 2020 · UC San Diego
  35. BindingDB Entry 50016907: A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma.
    BindingDB · 2023 · UC San Diego
  36. BindingDB Entry 50010748: Bifunctional Naphtho[2,3-
    BindingDB · 2021 · UC San Diego